Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gynecologic Cancers and Possible Solutions"
Check out the other parts of the presentation:
Part 1) ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD Mechanisms in Gynecologic Cancer"
Part 2) ESGO 2024 Insights: "The Heterogeneity of PARPi and BRCAm in Gynecologic Cancer"
Part 1) ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD Mechanisms in Gynecologic Cancer"
Part 2) ESGO 2024 Insights: "The Heterogeneity of PARPi and BRCAm in Gynecologic Cancer"
Comments 0
Login to view comments.
Click here to Login
